Benlysta at lasta: GSK finally snares HGS at $14 a share
This article was originally published in Scrip
Executive Summary
After months of wrangling and hostility, Human Genome Sciences has at last accepted GlaxoSmithKline's takeover bid after the UK-based giant sweetened its offer, adding $1.25 per share to its previous offer of $13 a share. At $14.25 per share, which is what the companies have finally closed on, HGS is valued at about $3.6 billion.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.